山东大学耳鼻喉眼学报 ›› 2016, Vol. 30 ›› Issue (2): 28-31.doi: 10.6040/j.issn.1673-3770.1.2016.08
邱杰,孙彦
QIU Jie, SUN Yan
中图分类号:
[1] Swierniak M, Wojcicka A, Czetwertynska M, et al. In-depth characterization of the microRNA transcriptome in normal thyroid and papillary thyroid carcinoma[J]. J Clin Endocrinol Metab., 2013, 98(8):1401-1409. [2] Network CGAR: Integrated genomic characterization of papillary thyroid carcinoma[J]. Cell, 2014, 159(3):676-690. [3] Qiu J, Zhang W W, Xia Q S, et al. RNA Sequencing identifies crucial genes in papillary thyroid carcinoma(PTC)progression[J]. Exp Mol Pathol, 2016, 100(1):151-159. [4] Kushchayeva Y, Jensen K, Burman J K, et al. Repositioning therapy for thyroid cancer: new insights on established medications[J]. Endocr Relat Cancer, 2014, 21(3):183-194. [5] Essig G F Jr, Porter K, Schneider D, et al. Fine needle aspiration and medullary thyroid carcinoma:the risk of inadequate preoperative evaluation and initial surgery when relying upon FNAB cytology alone[J]. Endocr Pract, 2013, 19(6):920-927. [6] Trimboli P, Seregni E, Treglia G, et al. Procalcitonin for detecting medullary thyroid carcinoma: a systematic review[J]. Endocr Relat Cancer, 2015, 22(3):157-164. [7] Pazaitou-Panayiotou K, Chrisoulidou A, Mandanas S, et al. Predictive factors that influence the course of medullary thyroid carcinoma[J]. Int J Clin Oncol, 2014, 19(3):445-451. [8] Barbet J, Campion L, Kraeber-Bodere F, et al. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubing-times in patients with medullary thyroid carcinoma[J]. J Clin Endocrinol Metab, 2005, 90(11):6077-6084. [9] Bugalho M J, Santos J R, Sobrinho L. Preoperative diagnosis of medullary thyroid carcinoma: fine needle aspiration cytology as compared with serum calcitonin measurement[J]. J Surg Oncol, 2005, 91(1):56-60. [10] Camacho C P, Lindsey S C, Melo M C, et al. Measurement of calcitonin and calcitonin gene-related peptide mRNA refines the management of patients with medullary thyroid cancer and may replace calcitonin-stimulation tests[J]. Thyroid, 2013, 23(3):308-316. [11] Wimalawansa S J. CGRP radioreceptor assay: a new diagnostic tool for medullary thyroid carcinoma[J]. J Bone Miner Res, 1993, 8(4):467-473. [12] Yap N S-J,Maher R, Learoyd D C. Any detectable thyroglobulin in lymph node biopsy washouts suggests local recurrence in differentiated thyroid cancer[J]. Endocr Connect, 2014, 3(1):150-155. [13] Milas M, Bsrbosa G F, Mitchell J, et al. Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer[J]. Ann Surg Oncol, 2009, 16(2):473-480. [14] Ersoz S, Sert H, Yandi M, et al. The significance of galectin-3 expression in immunocytochemical evaluation of thyroid fine needle aspiration cytology[J]. Pathol Oncol Res, 2008, 14(4):457-460. [15] Paunovic I, Isic T, Havelka M, et al. Combined immunohistochemistry for thyroid peroxidase, Galectin-3, CK19 and HBME-1 in differential diagnosis of thyroid tumors[J]. APMIS, 2012, 120(5):368-379. [16] Ma H,Xu S, Yan J, et al. The value of tumor markers in the diagnosis of papillary thyroid carcinoma alone and in combination[J]. Pol J Pathol, 2014, 65(3):202-209. [17] Liu Z, Li X, Shi L, et al. Cytokeratin 19, thyroperoxidase, HBME-1 and galectin-3 in evaluation of aggressive behavior of papillary thyroid carcinoma[J]. Int J Clin Exp Med, 2014, 7(8):2304-2308. [18] Calangiu C M, Simionescu C E, Stepan A E, et al. The expression of CK19, vimentin and E-cadherin in differentiation thyroid carcinomas[J]. Rom J Morphol Embryol, 2014, 55(3):919-925. [19] Tian X, Cong M, Zhou W, et al. Relationship between protein expression of VEGF-C, MMP-2 and lymph node metastasis in papillary thyroid cancer[J]. J Int Med Res, 2008, 36(4):699-703. |
[1] | 吴静,刘业海. 头颈部鳞状细胞癌的靶向治疗研究进展[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 97-102. |
[2] | 沈勤峰,沈小燕,朱荣强,蒋斐斐,郎军添. 鼻内镜下中鼻甲功能性部分切除治疗慢性鼻窦炎76例分析[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 82-85. |
[3] | 朱明娟,邢凯,亢泽峰,刘健. 甲状腺相关性眼病的诊断及治疗进展[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 110-113. |
[4] | 王坛,武珂,李连庆,宫丽丽. 皮下免疫治疗注射后出现全身不良反应的伴发因素及处理[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 71-74. |
[5] | 代亚错,李靖,万保罗,臧艳姿,黄颖铭. 个体化治疗咽喉部海绵状血管瘤二例[J]. 山东大学耳鼻喉眼学报, 2018, 32(4): 110-112. |
[6] | 刘义平,林远超. 负压引流防治腮腺术后涎瘘112例[J]. 山东大学耳鼻喉眼学报, 2018, 32(4): 65-67. |
[7] | 陈鸣,俞雪飞. 浅谈伴有变应性鼻炎的慢性鼻窦炎的治疗[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 18-22. |
[8] | 张桂敏,林鹏. 慢性鼻-鼻窦炎的内在型:从基础到临床[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 14-17. |
[9] | 覃纲,梁灼萍. 变应性真菌性鼻-鼻窦炎免疫治疗现状[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 23-26. |
[10] | 吴湘萍. 患者管理方式对变应性鼻炎舌下含服粉尘螨滴剂疗效的影响[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 68-72. |
[11] | 王仙,李颖,赵博军. 息肉样脉络膜血管病变诊疗进展[J]. 山东大学耳鼻喉眼学报, 2018, 32(2): 103-106. |
[12] | 钟建文,刘大波,罗向前,黄振云,仇书要,程超,杨李强,易新华,曾锦鸿. 可穿戴设备在儿童阻塞性睡眠呼吸暂停诊断中的应用[J]. 山东大学耳鼻喉眼学报, 2018, 32(2): 30-33. |
[13] | 高进良,年婉清,李烁. 鼻内镜手术联合鼻用糖皮质激素治疗腺样体肥大性[J]. 山东大学耳鼻喉眼学报, 2018, 32(2): 38-42. |
[14] | 吕丹,李明霞,马兰枝,张馨元,肖浩,陈飞,刘均,李珍. 累及纵膈的头颈部丛状I型神经纤维瘤病两例[J]. 山东大学耳鼻喉眼学报, 2018, 32(1): 82-86. |
[15] | 李俏丽,李超,王薇,蔡永聪,孙荣昊,周雨秋,税春燕, 黄璐,涂静. 术后放化疗后复发并侵及侧颅底的原发性腮腺鳞状细胞癌一例[J]. 山东大学耳鼻喉眼学报, 2018, 32(1): 87-88. |
|